Plasma NFL, GFAP, sTREM2, pTau231, and clinical severity in progressive supranuclear palsy
Seungmin Lee, Heejung Kim, Ryul Kim, Bora Jin, Seoyeon Kim, Su Hyeon Ha, Jung Hwan Shin, Beomseok Jeon, Han-Joon Kim, Jee-Young Lee · 2025
Read Plasma NFL, GFAP, sTREM2, pTau231, and clinical severity in progressive supranuclear palsy by Seungmin Lee, Heejung Kim, Ryul Kim, Bora Jin, Seoyeon Kim, Su Hyeon Ha, Jung Hwan Shin, Beomseok Jeon, Han-Joon Kim, Jee-Young Lee (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12743097.txt.
Description
Seungmin Lee and colleagues measure four blood markers against severity in progressive supranuclear palsy. Their study from twenty twenty-five uses a Korean patient cohort. This movement disorder lacks simple blood measures of progression. Candidate markers cover nerve damage, inflammation, and tau protein.
Sixty-eight patients were compared with thirty healthy controls. One marker, neurofilament light chain, clearly differed between groups. Its level tracked clinical rating scale severity closely. It also tracked lower thinking test scores in patients. Marker interrelations appeared in patients but not controls. A three-marker combination separated groups best overall. Blood testing could ease monitoring of this rare disease.
Catalog record
| CREATOR | Seungmin Lee, Heejung Kim, Ryul Kim, Bora Jin, Seoyeon Kim, Su Hyeon Ha, Jung Hwan Shin, Beomseok Jeon, Han-Joon Kim, Jee-Young Lee |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 40 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |